Markets

News Details

( 07 Nov 2019)
Sun Pharma. posts Q2 net profit of Rs 823.16 cr

The company reported standalone net profit during the quarter stood at Rs 823.16 crore compared to net loss of Rs 906.42 crore in the previous year quarter.

Net revenue of the company rose substantially by 44.99 per cent at Rs 3,215.01 crore in July-September quarter of this fiscal as against Rs 2,217.42 crore in the corresponding period last year.

During July-September quarter, operating expenses increased by 13.34 per cent to Rs 2,538.38 crore from Rs 2,239.61 crore in year ago period.

Other Income dipped by 51.53 per cent at Rs 258.33 crore versus (Sep'18 Rs 532.97 crore).

Operating Profit surged by 1299.92 per cent to Rs 834.91 crore as against Rs 59.64 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 865.43 per cent in September quarter.

Interest declined by 24.38 per cent y-o-y to Rs 114.47 crore, while Taxation increased by 50.96 per cent at Rs 16.47 crore (Sep'18 Rs 10.91 crore).